These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 19908091)

  • 1. One year clinical outcomes of renal artery stenting: the results of ODORI Registry.
    Sapoval M; Tamari I; Goffette P; Downes M; Senechal Q; Fanelli F; Reimer P; Negaiwi Z; De Cassin P; Heye S; Korobov V; Tsetis D; Abada H
    Cardiovasc Intervent Radiol; 2010 Jun; 33(3):475-83. PubMed ID: 19908091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirolimus-eluting versus bare-metal low-profile stent for renal artery treatment (GREAT Trial): angiographic follow-up after 6 months and clinical outcome up to 2 years.
    Zähringer M; Sapoval M; Pattynama PM; Rabbia C; Vignali C; Maleux G; Boyer L; Szczerbo-Trojanowska M; Jaschke W; Hafsahl G; Downes M; Bérégi JP; Veeger NJ; Stoll HP; Talen A
    J Endovasc Ther; 2007 Aug; 14(4):460-8. PubMed ID: 17696619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the safety and effectiveness of renal artery stenting after unsuccessful balloon angioplasty: the ASPIRE-2 study.
    Rocha-Singh K; Jaff MR; Rosenfield K;
    J Am Coll Cardiol; 2005 Sep; 46(5):776-83. PubMed ID: 16139124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nine-month results of the REFORM study: a prospective, single-arm, multicenter clinical study of the safety and effectiveness of the Formula™ balloon-expandable stent for treatment of renal artery stenosis.
    Bersin RM; Ansel G; Rizzo A; Bob Smouse H; Sinha S; Sachar R; Dave R; Weinstock BS; Feldman R; Roubin GS
    Catheter Cardiovasc Interv; 2013 Aug; 82(2):266-73. PubMed ID: 22581488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant reduction in systolic blood pressure following renal artery stenting in patients with uncontrolled hypertension: results from the HERCULES trial.
    Jaff MR; Bates M; Sullivan T; Popma J; Gao X; Zaugg M; Verta P;
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):343-50. PubMed ID: 22511402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-profile stent system for treatment of atherosclerotic renal artery stenosis: the GREAT trial.
    Sapoval M; Zähringer M; Pattynama P; Rabbia C; Vignali C; Maleux G; Boyer L; Szczerbo-Trojanowska M; Jaschke W; Hafsahl G; Downes M; Beregi JP; Veeger N; Talen A
    J Vasc Interv Radiol; 2005 Sep; 16(9):1195-202. PubMed ID: 16151060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Objective performance goals of safety and blood pressure efficacy for clinical trials of renal artery bare metal stents in hypertensive patients with atherosclerotic renal artery stenosis.
    Rocha-Singh KJ; Novack V; Pencina M; D'Agostino R; Ansel G; Rosenfield K; Jaff MR
    Catheter Cardiovasc Interv; 2011 Nov; 78(5):779-89. PubMed ID: 21648052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Balloon angioplasty, with and without stenting, versus medical therapy for hypertensive patients with renal artery stenosis.
    Jenks S; Yeoh SE; Conway BR
    Cochrane Database Syst Rev; 2014; 2014(12):CD002944. PubMed ID: 25478936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ten-year experience with renal artery in-stent stenosis.
    Stone PA; Campbell JE; Aburahma AF; Hamdan M; Broce M; Nanjundappa A; Bates MC
    J Vasc Surg; 2011 Apr; 53(4):1026-31. PubMed ID: 21215576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal artery angioplasty and stent placement: predictors of a favorable outcome.
    Burket MW; Cooper CJ; Kennedy DJ; Brewster PS; Ansel GM; Moore JA; Venkatesan J; Henrich WL
    Am Heart J; 2000 Jan; 139(1 Pt 1):64-71. PubMed ID: 10618564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of reoccurring instent restenosis following reintervention after stent-supported renal artery angioplasty.
    Zeller T; Sixt S; Rastan A; Schwarzwälder U; Müller C; Frank U; Bürgelin K; Schwarz T; Hauswald K; Brantner R; Noory E; Neumann FJ
    Catheter Cardiovasc Interv; 2007 Aug; 70(2):296-300. PubMed ID: 17630674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of renal artery stenting in an Australian population.
    Ruchin PE; Baron DW; Wilson SH; Boland J; Muller DW; Roy PR
    Heart Lung Circ; 2007 Apr; 16(2):79-84. PubMed ID: 17317314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary renal artery stenting: characteristics and outcomes after 363 procedures.
    Lederman RJ; Mendelsohn FO; Santos R; Phillips HR; Stack RS; Crowley JJ
    Am Heart J; 2001 Aug; 142(2):314-23. PubMed ID: 11479472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proper patient selection yields significant and sustained reduction in systolic blood pressure following renal artery stenting in patients with uncontrolled hypertension: long-term results from the HERCULES trial.
    Chrysant GS; Bates MC; Sullivan TM; Bachinsky WB; Popma JJ; Peng L; Omran HL; Jaff MR;
    J Clin Hypertens (Greenwich); 2014 Jul; 16(7):497-503. PubMed ID: 24909590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical predictors of improved long-term blood pressure control after successful stenting of hypertensive patients with obstructive renal artery atherosclerosis.
    Rocha-Singh KJ; Mishkel GJ; Katholi RE; Ligon RA; Armbruster JA; McShane KJ; Zeck KJ
    Catheter Cardiovasc Interv; 1999 Jun; 47(2):167-72. PubMed ID: 10376497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of renal artery stenting following suboptimal renal angioplasty for de novo and restenotic ostial lesions: results from a nonrandomized, prospective multicenter registry.
    Laird JR; Rundback J; Zierler RE; Becker GJ; O'Shaughnessy C; Shuck JW; Allie D; Olin JW; Cantwell-Gab K; Thomas J;
    J Vasc Interv Radiol; 2010 May; 21(5):627-37. PubMed ID: 20304680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Four-year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis.
    Dorros G; Jaff M; Mathiak L; Dorros II; Lowe A; Murphy K; He T
    Circulation; 1998 Aug; 98(7):642-7. PubMed ID: 9715856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of arterial stenting on kidney function for patients with ostial atherosclerotic renal artery stenosis and renal insufficiency.
    Beutler JJ; VAN Ampting JMA; Ven PJGV; Koomans HA; Beek FJA; Woittiez AJ; Mali WPTM
    J Am Soc Nephrol; 2001 Jul; 12(7):1475-1481. PubMed ID: 11423576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of renal artery stent combined with optimal medical therapy in patients with severe atherosclerotic renal artery stenosis.
    Jiang X; Peng M; Li B; Dong H; Che W; Zou Y; Yang Y; Gao R
    Curr Med Res Opin; 2016 Oct; 32(sup2):3-7. PubMed ID: 27779455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of atherosclerotic ostial renal artery stenosis with the intravascular stent.
    Tuttle KR; Chouinard RF; Webber JT; Dahlstrom LR; Short RA; Henneberry KJ; Dunham LA; Raabe RD
    Am J Kidney Dis; 1998 Oct; 32(4):611-22. PubMed ID: 9774123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.